• Accueil
• britta
• Britta Weigelt, PhD - MSK Molecular Geneticist

Britta Weigelt, PhD - MSK Molecular Geneticist

5 (234) · € 21.50 · En Stock

Targeting Minimal Residual Disease in Ovarian Cancer

Memorial Sloan Kettering Cancer Center on LinkedIn: Dr. Scott

The Britta Weigelt Lab Memorial Sloan Kettering Cancer Center

Pathogenic germline variants in patients with endometrial cancer

Pathogenic germline variants in patients with endometrial cancer

Immunogenicity and therapeutic targeting of a public neoantigen

Medizinische Hochschule Hannover : Corona-News 2020 to 2021

Immune and malignant cell phenotypes of ovarian cancer are

2023 BRCA Symposium

Genetics and Genomics Dr. Roisin O'Cearbhaill slides

The Britta Weigelt Lab Memorial Sloan Kettering Cancer Center

Our People Break Through Cancer